Agentic AI for Value and Market Access: turning evidence and policy into a VBP win engine

Market access used to be episodic. A dossier refresh here. A policy review there. A pricing corridor update when leadership demanded it. That cadence no longer matches the way MedTech is bought.

Procurement is now more explicit about what it will and will not award: measurable outcomes, credible total cost-of-care framing, sustainability evidence that can be scored, and a supplier posture that can withstand scrutiny across legal, cyber, and governance checkpoints. For market access teams, the challenge isn’t lack of intent — it’s throughput. Evidence is scattered. Policies shift constantly. Value stories fragment by region. Contract performance is hard to instrument. And the “last mile” of procurement readiness often collapses into manual rework.

This is where Agentic AI becomes less of a technology story and more of an operating model: a system designed to autonomously gather, structure, and maintain the evidence, policy intelligence, and outcome frameworks required to win in a value-based procurement environment — at scale, across markets, without scaling headcount linearly.

The new market access problem isn’t knowledge — it’s operational latency

Most market access leaders are not short on expertise. They are short on time, alignment, and repeatability.
You can see it in the common failure patterns:

• Evidence generation happens, but translation into buyer-ready narratives is slow and inconsistent.
• Policy tracking exists, but it’s reactive — teams discover changes after they’ve already shaped tenders or reimbursement decisions.
• Value-based procurement is discussed, but measurement frameworks are not operationalised, so programmes stall after pilots.
• Sustainability is increasingly demanded, yet evidence is fragmented across suppliers, functions, and geographies — leaving teams exposed at the point of evaluation.
• “Answering procurement” becomes a project in itself: repeating security questionnaires, rewriting annexes, rebuilding proof, and re-approving narratives for each bid.

In practical terms, market access is being judged by the speed at which it can produce certainty. Not only “is the product clinically valuable?”, but “can the supplier govern it, evidence it, and sustain it in the field?”
Agentic AI is emerging as the most viable approach to close this gap because it treats market access as a continuous system of signals and responses — not a set of disconnected documents.

What Agentic AI is (in market access terms)

Agentic AI is best understood as an orchestrated set of specialised “agents” designed to execute specific workstreams within a controlled governance framework. Not a chatbot. Not a single model. A workflow engine built for evidence operations.

In market access, those agents typically do four jobs:

• Discover and ingest signals (evidence, policies, tender requirements, sustainability frameworks, buyer behaviours)
• Structure and classify that information into a consistent taxonomy (claims, endpoints, payer types, geographies, scoring criteria)
• Generate decision-grade outputs (value messages, evidence maps, annex packs, KPI frameworks)
• Maintain currency over time (monitor, alert, re-map, and trigger updates as markets evolve)

The distinction is critical: market access doesn’t need more content. It needs a system that keeps the right content accurate, current, auditable, and aligned to how procurement evaluates risk and value.